Georgian Dictionary of Public Health
Photo: Tbilisi, by Geo Max (Flickr), cropped for layout · Licensed CC BY-SA 2.0 · Source A feature on the…
Editor's Top Picks
Balance Problems and the Vulnerable Mind: A Gene Study Links the Inner Ear to Cognition
Vestibular dysfunction — the medical term for chronic balance problems rooted in the inner ear — is increasingly suspected of…
Submit Your Paper to GMJ
Moldova probation centres identify 136 people with opioid disorders through innovative screening programme
Research across 10 Moldovan probation centres identified 136 people with opioid use disorder among 900 participants, with 97% treatment retention…
WOAH Calls for Global Phase-Out of Lead Hunting Ammunition to Protect Wildlife and Human Health
The World Organisation for Animal Health calls for global elimination of lead hunting ammunition, citing 10-20 million annual bird deaths…
Popular Anti-Aging Drug Combination Causes Severe Brain Damage in Mice
A widely researched anti-aging drug combination caused severe brain damage in mice, including myelin loss and cognitive changes resembling "chemo…
PAHO Partners with Mundo Sano Foundation to Eliminate Neglected Diseases and Cervical Cancer
PAHO and Argentina's Mundo Sano Foundation partner to eliminate neglected tropical diseases affecting 200 million people in the Americas. The…
Largest Clinical Trial Reveals Optimal Treatment for Rare Chiari Malformation
A nationwide clinical trial of 394 patients has provided definitive evidence for optimal surgical treatment of Chiari malformation and syringomyelia.…
Genomic instability fuels cancer resistance through newly identified cellular pathway
New research reveals how genomic instability in ovarian cancer activates the STING-WNT pathway, creating protective myofibroblasts that drive both immune…
UK Nursing Regulator Failed to Screen Criminal Records for 12 Years
The UK's nursing regulator admits to 12 years of systematic failures in reviewing criminal records for healthcare professionals. More than…
Zanidatamab Plus Chemotherapy Shows 56% Improvement in HER2+ Gastric Cancer
Zanidatamab plus chemotherapy reduced disease progression risk by 44% compared to trastuzumab in HER2-positive gastroesophageal cancer patients. The phase III…